The Effect of Reminiscence Therapy in Elderly
Psychological Well-Being and Mindfulness in the Elderly: The Effect of Reminiscence Therapy
1 other identifier
interventional
90
1 country
1
Brief Summary
In this study titled "Psychological Well-Being and Awareness in the Elderly: The Effect of Reminiscence Therapy", patients will be randomly divided into two groups as experimental and control groups. No intervention will be made to the patients in the control group. Reminiscence therapy will be applied to the patients in the experimental group. Participants will be asked to fill out the scale forms after accepting to participate in the study and obtaining their consent. In addition, after the reminiscence therapy is completed, the experimental and control groups will be asked to fill out the post-test forms. The following questions will be answered in the study;
- Does reminiscence therapy affect the psychological well-being levels of the elderly?
- Does reminiscence therapy affect the awareness levels of the elderly?
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2025
CompletedFirst Submitted
Initial submission to the registry
April 24, 2025
CompletedFirst Posted
Study publicly available on registry
May 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2025
CompletedMay 9, 2025
April 1, 2025
2 months
April 24, 2025
May 7, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Psychological well-being Scale
scale score average, It is a single-factor scale consisting of 8 items on a 7-point Likert type. Scores range from 8 to 56. A high score obtained from the scale indicates that the person has many psychological resources and strengths.
1 months
Study Arms (2)
Experimental Group
EXPERIMENTALReminiscence Therapy can be applied as 1 or 2 sessions per week and the longest is 1.5 hours, so it will be applied for 5 weeks, 3 days a week (Monday, Wednesday, Friday) with 2 sessions per day. Each session is planned to last an average of 1.5 hours according to the answers from the elderly. The elderly individuals in the experimental group will be divided into 3 groups. Each group will consist of 15 people. The sessions will include, respectively, getting to know each other, childhood, places lived, holidays-festivals, foods-cooking, unforgettable historical periods, favorite music, movies specific to the period, family life-values in life-achievements, evaluation and closing topics.
Control Group
NO INTERVENTIONThere will be no intervention in the control group during the research process.
Interventions
Reminiscence Therapy can be applied as 1 or 2 sessions per week and the longest is 1.5 hours, so it will be applied for 5 weeks, 3 days a week (Monday, Wednesday, Friday) with 2 sessions per day. Each session is planned to last an average of 1.5 hours according to the answers from the elderly. The elderly individuals in the experimental group will be divided into 3 groups. Each group will consist of 15 people. The sessions will include, respectively, getting to know each other, childhood, places lived, holidays-festivals, foods-cooking, unforgettable historical periods, favorite music, movies specific to the period, family life-values in life-achievements, evaluation and closing topics.
Eligibility Criteria
You may qualify if:
- Being over 65 years old
- not having any serious psychiatric disorders
- not having any diseases such as dementia etc.
You may not qualify if:
- Having a serious psychiatric disorder
- Not being able to attend sessions during the research process
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ağın Community Health Center
Elâzığ, 23960, Turkey (Türkiye)
Study Officials
- PRINCIPAL INVESTIGATOR
Güzel Nur YILDIZ, Dr
Muş Alparslan University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 24, 2025
First Posted
May 9, 2025
Study Start
April 1, 2025
Primary Completion
May 30, 2025
Study Completion
June 30, 2025
Last Updated
May 9, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share